Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis of New Anthracyline Derivatives Containg Acetylsalicyclic or Palmitic Acid Moiety.

  • Published : 20010600
Download PDF
⟨ Previous Next ⟩

Abstract

The potential anticancer agents new anthracycline derivatives (2~9) have been synthesized from daunomycin (1a) and doxorubicin (1b) ad starting materials. Compounds 2 and 6 were prepared by the nucleophilic displacement type esterification of a 14-bromodaunomycin (1c) with a acetylsalicylic and palmitic acid in triethylamine, respectively. Compound 3 and 7 were obtained from daunomycin (1a) by direct amidation with the corresponding acids in the presence of EDCI and PP as esterification regents. Whereas 4 and 8 were prepared by reaction of doxorubicin (1b) with one equivalent of acetylsalicylic and palmitic acid using DCC/DMAP, respectively, 5 and 9 were obtained from 1b by acylation with two equivalents of the corresponding acids using EDCI/PP reagents.

Keywords

References

  1. Med. Res. Rev. v.4 no.153 Acamone, F.
  2. Current Status and New Developments. Crooke, S. T.;Reich, S. D.(Eds.)
  3. Molecular Pharmacology. v.36 no.251 Gresh, N.;Pullman, B.;Arcamone, F.;Menozzi, M.;Tonani, R.
  4. Nature New Biol. v.235 no.17 Pigram, W.;Fuller, W.;Hamilton, L.
  5. Science. v.226 no.466 Tewey, K. M.;Rowe T. C.;Yang, L.;Halligan, B. D.;Liu, L. F.
  6. DNA Topology and Its Biological Effects. Cozarelli, N. R.;Wang, J. C.
  7. DNA Topoisomerases and Their Inhibition by Anthracyclines. Anthracycline Antibiotics. Pommier, Y.
  8. US Patent 5 744455. Speyer.;Leonard, J.;Muggia.;Mario, F.;Green.;David, M.;
  9. US Patent 4256632. Levin, Y.;Sela, B. A.
  10. US Patent 430664. Sakamaki.;Takeuchi, T.;Naganama, H.;Tatsuta, K.
  11. US Patent 4360664. Umezawa, H.;Takeuchi, T.
  12. Cell Structure and Function. v.20 no.5 Hyrayama, E.;Hase, H.;Nakano, Y.;Kim, J.
  13. Thrombosis Research. v.75 no.1 Bernat, A.;Herbert, J. M.
  14. Journal of Biological Chemistry. v.271 no.32 Laive, Y.;Cao, H. T.;Bursten, S. L.;Giuliano, A. E.;Cabot, M. C.
  15. Bull. Korean Chem. Soc. v.20 no.551 Rho, Y. S.;Choi, Y.;Kim, G.;Sin, H.;Yoo, D. J.;Kim, S. H.;Cheong, C.
  16. Bull. Korean Chem. Soc. v.19 no.1059 Rho, Y. S.;Kim, S. Y.;Cho, I.;Kang, H. S.;Yoo, D. J.;Cheong, C.
  17. Bull. Korean Chem. Soc. v.19 no.74 Rho, Y. S.;Park, S.;Kim, S. Y.;Cho, I.;Lee, C.;Kang, H. S.;Cheong, C.
  18. J. Chem. v.54 no.5110 Hauser, F. M.;Hewawasam, P.;Rho, Y. S.
  19. Bull. Korean. Chem. Soc. v.20 no.1517 Rho, Y. S.;Ko, H. K.;Sin, H.;Yoo, D. J.
  20. Bull. Korean. Chem. Soc. v.21 no.774 Rho, Y .S.;Park, S.;Kim, W. J.;Yoo, D. J.;Kang, H. S.
  21. Synthesis of new anthracycline derivatives including a pyruvic, aspartic, or N-acetylaspartic acid molecule. Rho, Y. S.;Park, S.;Kim, W. J.;Kim, G.;Yoo, D. J.;Kang, H. S.
  22. Novel Anthracycline Derivatives and Their Preparation. Rho, Y. S.;Park, S. C.;Kang, H. S.
  23. Tetrahedron Lett. v.25 no.43 Kim, S.;Lee, J. I.;Ko, Y. K.
  24. Synthesis. v.689 Takeda, K.;Ayabe, A.;Suzuki, M.;Konda, Y.;Harigaya, Y.
  25. Synthesis. v.506 Janecki, T.;Bodalski, R.
  26. Synthesis. v.544 Alaiz, M.;Giron, J.;Hidelgo, F. J.;de la Maza, M. P.;Millan, F.;Zamora, R.;Vioque, E.
  27. J. Org. Chem. v.59 no.1238 Kanazawa, A. M.;Olsen, R. K.;Ramasamy, K.
  28. J. Org. Chem. v.59 no.1238 Dhaon, M. K.;Olsen, R. K.;Ramasamy, K.
  29. Synthesis. v.819 Nielsen, O.;Buchardt, O.
  30. Purification of Laboratory Chemicals. Perrin, D. D.;Armarego, W. L. F.

Cited by

  1. Identification of fatty acid esters and hydrocarbon derivatives from Cyrtocarpa procera Kunth by GC-MS vol.20, pp.1, 2006, https://doi.org/10.1080/14786410500045358
  2. Synthesis of New Anthracycline Derivatives Containing Lactic or Stearic Acid Moiety vol.27, pp.9, 2006, https://doi.org/10.5012/bkcs.2006.27.9.1359
  3. Invitro study of multiwall carbon nanotubes (MWCNTs) with adsorbed mitoxantrone (MTO) as a drug delivery system to treat breast cancer vol.4, pp.36, 2001, https://doi.org/10.1039/c4ra02366h
  4. Synthesis and evaluation of new peptide-linked doxorubicin conjugates as prodrugs activated by prostate-specific antigen vol.29, pp.7, 2001, https://doi.org/10.1007/s00044-020-02573-w